Abstract
Increased arterial stiffness and impaired vasodilator response have been associated with cardiovascular events in high-risk patients. However, whether arterial changes predict the occurrence of hypertensive complications is still unclear. Therefore, we designed a hospital-based cohort study to examine the prognostic impact of arterial functional changes on stroke and cardiovascular diseases in hypertensive patients. The study employed 676 patients with essential hypertension. At baseline, we evaluated second-derived photoplethysmography, carotid-femoral pulse wave velocity (PWV), and forearm reactive hyperemia. We classified subjects into quartile groups according to the baseline measurements of these evaluations and assessed the ability of each measure to predict stroke and cardiovascular diseases (CVD). During a mean follow-up period of 57 months, 52 strokes, 40 CVD, and 22 deaths were recorded. Kaplan-Meier analysis revealed that patients in the highest quartile of PWV showed a higher frequency of stroke and CVD (p<0.0001) and total mortality (p=0.0016), and those in the highest quartile of reactive hyperemia showed a lower frequency of stroke and CVD (p=0.0415). A Cox hazard model identified that classification in the highest quartile of PWV (relative risk=2.717) and reactive hyperemia (0.416) were predictive of stroke and CVD after adjustment for other risk factors. In subjects who did not experience stroke or CVD before the study period (n=558), only PWV was related with the occurrence of stroke and CVD based on the Cox hazard model. In conclusion, increased aortic stiffness evaluated by PWV is more prognostic of cardiovascular events in hypertensive patients than several non-invasive atherosclerotic evaluations.
Similar content being viewed by others
Article PDF
References
Staessen JA, Wang JG, Thijs L : Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21: 1055–1076.
Weber MA : The measurement of arterial properties in hypertension. Am J Hypertens 2001; 14: 183–185.
Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM : Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63: 1852–1860.
Asmar R, Rudnichi A, Blacher J, London GM, Safar ME : Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens 2001; 14: 91–97.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG : Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085–2090.
Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME : Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046–2050.
Takazawa K, Tanaka N, Fujita M, et al: Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform. Hypertension 1998; 32: 365–370.
Komai N, Ohishi M, Moriguchi A, et al: Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation. Hypertens Res 2002; 25: 5–10.
Higashi Y, Yoshizumi M : New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation. J Pharmacol Sci 2003; 93: 399–404.
Komai N, Ohishi M, Morishita R, et al: Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Am J Hypertens 2002; 15: 499–506.
1999 World Health Organization-International Society of Hypertension Guideline for the Management of Hypertension. J Hypertens 1999; 17 151–183.
Benetos A, Adamopoulos C, Bureau JM, et al: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105: 1202–1207.
Shoji T, Emoto M, Shinohara K, et al: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001; 12: 2117–2124.
Mitchell GF, Parise H, Vita JA, et al: Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 2004; 44: 134–139.
Mitchell GF, Vita JA, Larson MG, et al: Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 2005; 112: 3722–3728.
Woodman RJ, Kingwell BA, Beilin LJ, Hamilton SE, Dart AM, Watts GF : Assessment of central and peripheral arterial stiffness: studies indicating the need to use a combination of techniques. Am J Hypertens 2005; 18: 249–260.
Boutouyrie P, Tropeano AI, Asmar R, et al: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10–15.
Blacher J, Asmar R, Djane S, London GM, Safar ME : Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111–1117.
Asmar RG, London GM, O’Rourke ME, Safar ME : Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38: 922–926.
Munakata M, Nagasaki A, Nunokawa T, et al: Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17: 1050–1055.
Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T : Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002; 17: 1513–1517.
Munakata M, Nunokawa T, Yoshinaga K, Toyota T : Brachial-ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension—a Japanese Trial on the Prognostic Implication of Pulse Wave Velocity (J-TOPP). Hypertens Res 2006; 29: 515–521.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terai, M., Ohishi, M., Ito, N. et al. Comparison of Arterial Functional Evaluations as a Predictor of Cardiovascular Events in Hypertensive Patients: The Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) Study. Hypertens Res 31, 1135–1145 (2008). https://doi.org/10.1291/hypres.31.1135
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1135
Keywords
This article is cited by
-
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy
Current HIV/AIDS Reports (2021)
-
Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects
European Journal of Nutrition (2019)
-
Arterial stiffness and increased cardiovascular risk in chronic kidney disease
International Urology and Nephrology (2015)
-
Prognostic impact of regional arterial stiffness in hypertensive patients
Heart and Vessels (2015)
-
Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study
Journal of Cardiovascular Magnetic Resonance (2014)